Automated Microbiology Market Size, Share, Opportunities, And Trends By Diagnostic Technologies (Detection Techniques, DNA Sequencing, DNA and RNA Probe Technology), By End User (Biotechnology Industries, Clinical Laboratories, Others), And By Geography - Forecasts From 2025 To 2030

  • Published : Aug 2025
  • Report Code : KSI061610957
  • Pages : 144
excel pdf power-point

Automated Microbiology Market Size:

The Automated Microbiology Market is expected to grow from USD 7.865 billion in 2025 to USD 12.519 billion in 2030, at a CAGR of 9.74%.

This research study examines the Automated Microbiology market by diagnostic technologies, end users, and geography. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to demand, supply, and sales, in addition to the recent developments, have been provided in this report.  The report also analyzes key players in the Automated Microbiology market. The report provides a comprehensive forecast up to the period 2022 for various key segments, with 2016 as the base year.

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the Automated Microbiology market, offering stakeholders a better understanding of the key factors affecting the overall market environment.

The first step towards determining the Automated Microbiology market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases, and journals among others. Both bottom-up and top-down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Automated Microbiology value chain across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentations, charts, graphics, and other different formats helping the clients to a faster and more efficient understanding of the market. Under this phase, complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

The competitive intelligence section deals with major players in the market, their market share analysis, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Bio-Rad Laboratories, Inc and QIAGEN.

Automated Microbiology Market Segmentation

  • By Solutions
    • Hardware
    • Software
    • Services
  • By Technology
    • Detection Technique
    • DNA & RNA Probe Seqeuncing
    • DNA Sequencing
    • Others
  • By End-User
    • Pharmaceutical & Biotech Companies
    • Clinical Laboratories
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. AUTOMATED MICROBIOLOGY MARKET BY SOLUTIONS

5.1. Introduction

5.2. Hardware

5.3. Software

5.4. Services

6. AUTOMATED MICROBIOLOGY MARKET BY TECHNOLOGY

6.1. Introduction

6.2. Detection Technique

6.3. DNA & RNA Probe Sequencing

6.4. DNA Sequencing

6.5. Others

7. AUTOMATED MICROBIOLOGY MARKET BY END-USER

7.1. Introduction

7.2. Pharmaceutical & Biotech Companies

7.3. Clinical Laboratories

7.4. Others

8. AUTOMATED MICROBIOLOGY MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentian

8.3.3. Others

8.4. Europe

8.4.1. Germany 

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Bio-Rad Laboratories, Inc. 

10.2. QIAGEN

10.3. BECKMAN COULTER

10.4. Becton Dickinson

10.5. bioMerieux 

10.6. Interscience

10.7. Rapid Micro Biosystems, Inc. 

10.8. Sigma-Aldrich

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Bio-Rad Laboratories, Inc. 

QIAGEN

BECKMAN COULTER

Becton Dickinson

bioMerieux 

Interscience

Rapid Micro Biosystems, Inc. 

Sigma-Aldrich